{"id":"https://openalex.org/W2239249354","doi":"https://doi.org/10.1200/jco.1998.16.9.2953","title":"Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.","display_name":"Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.","publication_year":1998,"publication_date":"1998-09-01","ids":{"openalex":"https://openalex.org/W2239249354","doi":"https://doi.org/10.1200/jco.1998.16.9.2953","mag":"2239249354","pmid":"https://pubmed.ncbi.nlm.nih.gov/9738563"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1998.16.9.2953","doi":"https://doi.org/10.1200/jco.1998.16.9.2953","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1998.16.9.2953","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017494786","display_name":"Evanthia Galanis","orcid":"https://orcid.org/0000-0001-8014-786X","observed_orcids":["https://orcid.org/0000-0001-8014-786X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E Galanis","raw_affiliation_strings":["Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034104319","display_name":"Jan C. Buckner","orcid":"https://orcid.org/0000-0002-8688-266X","observed_orcids":["https://orcid.org/0000-0002-8688-266X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J C Buckner","raw_affiliation_strings":["Mayo Clinic Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050514405","display_name":"Patrick A. Burch","orcid":"https://orcid.org/0000-0001-9387-5532","observed_orcids":["https://orcid.org/0000-0001-9387-5532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P A Burch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080834383","display_name":"P L Schaefer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P L Schaefer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039903226","display_name":"Robert P. Dinapoli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R P Dinapoli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013202100","display_name":"Paul J. Novotny","orcid":"https://orcid.org/0000-0002-1526-9817","observed_orcids":["https://orcid.org/0000-0002-1526-9817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P J Novotny","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110883848","display_name":"Bernd Walter Scheithauer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B W Scheithauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068223396","display_name":"K. M. Rowland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K M Rowland","raw_affiliation_strings":["Carle Illinois College of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carle Illinois College of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018262872","display_name":"Allen M. Vukov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A M Vukov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110163313","display_name":"James A. Mailliard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J A Mailliard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108265719","display_name":"Roscoe F. Morton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R F Morton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2954,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.81780538,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"16","issue":"9","first_page":"2953","last_page":"2958"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-glioma","display_name":"recurrent glioma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mechlorethamine","display_name":"mechlorethamine","score":0.9369999766349792},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9110000133514404},{"id":"https://openalex.org/keywords/procarbazine","display_name":"procarbazine","score":1.0},{"id":"https://openalex.org/keywords/nitrogen-mustard","display_name":"nitrogen mustard","score":0.7250000238418579},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.6449999809265137},{"id":"https://openalex.org/keywords/anaplastic-oligodendroglioma","display_name":"anaplastic oligodendroglioma","score":0.875},{"id":"https://openalex.org/keywords/anaplastic-astrocytoma","display_name":"anaplastic astrocytoma","score":0.871999979019165},{"id":"https://openalex.org/keywords/low-grade-glioma","display_name":"low-grade glioma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.871999979019165},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.9340000152587891},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.8539999723434448},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7450000047683716},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C2779112685","wikidata":"https://www.wikidata.org/wiki/Q418656","display_name":"Procarbazine","level":5,"score":0.9460548162460327},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8988143801689148},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.7361294627189636},{"id":"https://openalex.org/C2779434656","wikidata":"https://www.wikidata.org/wiki/Q415378","display_name":"Lomustine","level":5,"score":0.6737115979194641},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6486808657646179},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5921604633331299},{"id":"https://openalex.org/C2778670039","wikidata":"https://www.wikidata.org/wiki/Q414004","display_name":"Nitrogen mustard","level":4,"score":0.5698825716972351},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5545060038566589},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.549227237701416},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5319735407829285},{"id":"https://openalex.org/C2779083369","wikidata":"https://www.wikidata.org/wiki/Q486092","display_name":"Anaplastic astrocytoma","level":4,"score":0.49662548303604126},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.48941341042518616},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40343695878982544},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34045928716659546},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.2802026569843292},{"id":"https://openalex.org/C2778880634","wikidata":"https://www.wikidata.org/wiki/Q177755","display_name":"Astrocytoma","level":3,"score":0.26469510793685913},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.05538776516914368}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001254","descriptor_name":"Astrocytoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008466","descriptor_name":"Mechlorethamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008466","descriptor_name":"Mechlorethamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009837","descriptor_name":"Oligodendroglioma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011344","descriptor_name":"Procarbazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011344","descriptor_name":"Procarbazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.1998.16.9.2953","doi":"https://doi.org/10.1200/jco.1998.16.9.2953","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1998.16.9.2953","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:9738563","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9738563","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G5141664634","display_name":"Community Clinical Oncology Program","funder_award_id":"U10CA037404","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6127403653","display_name":"North Central Cancer Treatment Group","funder_award_id":"U10CA025224","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6634865303","display_name":"Carle Cancer Center Community Clinical Oncology Program","funder_award_id":"U10CA035195","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1751296883","https://openalex.org/W1944104521","https://openalex.org/W1978092831","https://openalex.org/W1979300931","https://openalex.org/W2010496087","https://openalex.org/W2034500038","https://openalex.org/W2036371914","https://openalex.org/W2037394188","https://openalex.org/W2038835567","https://openalex.org/W2052596539","https://openalex.org/W2059481780","https://openalex.org/W2062727903","https://openalex.org/W2067384856","https://openalex.org/W2088925558","https://openalex.org/W2090505448","https://openalex.org/W2090595805","https://openalex.org/W2258639565","https://openalex.org/W2407808714","https://openalex.org/W2884633475"],"related_works":["https://openalex.org/W2258639565","https://openalex.org/W2040243935","https://openalex.org/W49957420","https://openalex.org/W2070785969","https://openalex.org/W2043005631","https://openalex.org/W2015131798","https://openalex.org/W2129244123","https://openalex.org/W2053131031","https://openalex.org/W2064542358","https://openalex.org/W7099298777"],"abstract_inverted_index":{"PURPOSE:":[0],"Previous":[1],"investigators":[2],"have":[3],"reported":[4,234],"responses":[5],"in":[6,143,151,160,170,175,181,235],"52%":[7],"of":[8,42,153,158,163,172,217,267,279],"patients":[9,38,101,156,173],"treated":[10,46],"with":[11,39,47,52,108,137,239],"mechlorethamine":[12],"(nitrogen":[13],"mustard),":[14],"vincristine,":[15],"and":[16,70,80,82,128,145,177,203,210,220,245,255,271],"procarbazine":[17,83],"(MOP)":[18],"for":[19,103,198],"recurrent":[20,43,236,240,246],"glioma.":[21],"To":[22],"confirm":[23,228],"these":[24],"promising":[25],"results,":[26],"we":[27],"conducted":[28],"a":[29],"phase":[30],"II":[31],"prospective":[32],"study.":[33],"PATIENTS":[34],"AND":[35],"METHODS:":[36],"Sixty-three":[37],"histologic":[40],"confirmation":[41],"glioma":[44],"were":[45,93,114,212,274],"the":[48,161,195,213,229,250,264,275],"MOP":[49],"regimen.":[50],"Patients":[51,238],"or":[53,62,125,243],"without":[54],"prior":[55],"chemotherapy":[56,201],"received":[57],"nitrogen":[58],"mustard":[59],"3":[60],"mg/m2":[61,75,85],"6":[63],"mg/m2,":[64],"respectively,":[65],"intravenously":[66,76],"on":[67,77,87],"days":[68,78,88],"1":[69,79,89],"8":[71],"plus":[72],"vincristine":[73],"2":[74],"8,":[81],"100":[84],"orally":[86],"to":[90,200,205],"14.":[91],"Cycles":[92],"repeated":[94],"every":[95],"28":[96],"days.":[97],"RESULTS:":[98],"Of":[99],"61":[100],"assessable":[102],"response,":[104,268],"eight":[105],"responded":[106],"(13%),":[107],"one":[109],"complete":[110],"response":[111,199,231,252],"(CR).":[112],"Responses":[113],"as":[115],"follows:":[116],"low-grade":[117,247],"gliomas,":[118],"19%;":[119],"anaplastic":[120,123,241],"astrocytomas,":[121],"11%;":[122],"oligodendrogliomas":[124,242],"oligoastrocytomas,":[126],"25%;":[127],"glioblastomas,":[129],"4.3%.":[130],"The":[131],"most":[132,214,276],"common":[133],"toxicity":[134,166],"was":[135,194,263],"myelosuppression":[136],"leukocyte":[138],"nadirs":[139,147],"less":[140,148],"than":[141,149],"1,000/microL":[142],"23%":[144],"platelet":[146],"25,000/microL":[150],"13%":[152],"patients.":[154],"Two":[155],"died":[157],"infection":[159],"setting":[162],"neutropenia.":[164],"Nonhematologic":[165],"included":[167],"neurosensory":[168],"changes":[169],"21%":[171],"(severe":[174],"3%)":[176],"severe":[178],"dermatologic":[179],"reactions":[180],"8%.":[182],"In":[183,258],"multivariate":[184,259],"analysis,":[185,260],"Eastern":[186],"Cooperative":[187],"Oncology":[188],"group":[189],"(ECOG)":[190],"performance":[191],"status":[192],"(PS)":[193],"best":[196,265],"predictor":[197,266],"(P=.01)":[202],"time":[204],"progression":[206],"(P=.008),":[207],"while":[208,269],"PS":[209,262,270],"grade":[211,273],"important":[215,277],"predictors":[216,278],"survival":[218],"(P=.002":[219],".05,":[221],"respectively).":[222,257],"CONCLUSION:":[223],"This":[224],"study":[225],"did":[226],"not":[227],"high":[230],"rate":[232],"previously":[233],"gliomas.":[237],"oligoastrocytomas":[244],"gliomas":[248],"had":[249],"highest":[251],"rates":[253],"(25%":[254],"19%,":[256],"ECOG":[261],"tumor":[272],"survival.":[280]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}